l 738167 has been researched along with Disease Models, Animal in 1 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askew, BC; Baldwin, JJ; Claremon, DA; Cook, JJ; Glass, JD; Gould, RJ; Hartman, GD; Holahan, MA; Lynch, JJ; McIntyre, CJ; Sitko, GR; Stranieri, MT | 1 |
1 other study(ies) available for l 738167 and Disease Models, Animal
| Article | Year |
|---|---|
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Topics: Adenosine Diphosphate; Animals; Azepines; Bleeding Time; Disease Models, Animal; Dogs; Drug Administration Routes; Fibrinolytic Agents; Macaca mulatta; Pan troglodytes; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombosis | 1997 |